Antheia Secures $80 Million Conditional Funding Commitment from Department of War's Office of Strategic Capital

The Quick Take
Financing supports Antheia's domestic manufacturing strategy to onshore critical medicine supply chains MENLO PARK, Calif., Oct. 18, 2026 /PRNewswire/ -- Antheia, the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, today announced it has...
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire.



